查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083358

獸用快速檢測市場：商業機會、成長要素、產業趨勢分析及2026-2035年預測

Veterinary Rapid Tests Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球獸醫快速檢測市場預計到 2025 年將達到 9.532 億美元，年複合成長率為 9.1%，到 2035 年將達到 23 億美元。

獸用快速檢測市場-IMG1

推動市場成長的因素包括：獸醫診療模式正從集中式診斷檢查室轉變為包括伴侶動物診所和畜牧養殖場在內的所有獸醫場所的即時檢測（POC​​T）模式。寵物飼養量的增加、對動物預防保健日益重視以及對快速診斷結果需求的成長，進一步促進了市場滲透。 「同一健康」舉措的影響力日益增強，也推動了動物和人類疾病的全面監測，進一步凸顯了快速診斷工具的重要性。橫向流動化驗技術成本的持續降低，提高了其在發展中地區和已開發地區的可近性和可負擔性。此外，多重檢測和數位化連接解決方案的進步提高了診斷準確性，並實現了即時數據共用。寵物飼主和畜牧養殖戶對疾病早期檢測意識的提高，進一步加速了快速診斷技術的普及，使其成為獸醫領域中動物健康產業中穩步成長的細分市場。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 9.532億美元
預測金額 23億美元
複合年成長率 9.1%

快速檢測套組盒預計到2025年將佔據67.6%的市場佔有率，並在2035年之前以9.9%的複合年成長率成長。此細分市場的主導地位得益於耗材的持續需求、其在多種動物疾病中的廣泛臨床應用，以及製造商為兼顧寵物和牲畜健康管理而不斷進行的創新。易用性、快速出結果以及適用於現場檢測等特點進一步推動了其在獸醫保健系統中的普及。

預計到2025年，獸醫院市佔率將達到39.7%，並在2035年之前以8.6%的複合年成長率成長。此細分市場的主導地位歸功於獸醫醫療服務提供者的高度集中，以及他們對院內診斷檢測的依賴，以便及時做出決策。診所仍然是獸醫醫療服務的主要網路基地台，尤其對於伴侶動物而言，快速檢測有助於制定即時治療方案和疾病管理。對即時診斷需求的不斷成長進一步鞏固了其在獸醫醫療服務中的核心地位。

預計到2025年，北美獸醫快速檢測市場將佔據40.5%的市場佔有率，並在2035年之前以8.3%的複合年成長率成長，繼續保持其在全球市場的主導地位。該地區主導的地位得益於較高的寵物飼養率、先進的獸醫基礎設施以及對診斷技術的積極應用。美國仍然是該地區需求的主要驅動力，這主要得益於眾多動物醫院的存在以及對動物疾病預防和早期檢測的日益重視。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 伴侶動物數量增加
      • 動物通用感染疾病發生率增加
      • 與其他檢測方法相比，快速診斷檢測的需求日益成長。
      • 寵物數量增加
    • 產業潛在風險與挑戰
      • 獸醫診斷的基礎設施有限。
      • 開發中國家缺乏獸醫學知識
      • 動物醫療保健成本不斷上漲
    • 市場機遇
      • 開發多參數攜帶式快速檢測解決方案
      • 獸醫診斷在新興市場和區域市場的擴張
  • 成長潛力分析
  • 技術展望
    • 目前技術
    • 新興技術
  • 價格分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 人工智慧和生成式人工智慧對市場的影響
  • 未來市場趨勢
  • 寵物數量統計數據

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 北美洲
    • 歐洲
    • 亞太地區
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

  • 快速檢測套組
  • 快速偵測讀數器

第6章 市場估計與預測：依測試類型分類，2022-2035年

  • 抗原快速檢測法
  • 快速抗體檢測法
  • 混合測試

第7章 市場估計與預測：依應用領域分類，2022-2035年

  • Viral
  • 寄生型
  • 細菌
  • 過敏
  • 其他用途

第8章 市場估算與預測：依動物類型分類，2022-2035年

  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 其他伴侶動物
  • 家畜
    • 牛
    • 豬
    • 家禽
    • 其他牲畜

第9章 市場估計與預測：依樣本類型分類，2022-2035年

  • 血
  • 屎
  • 血清
  • 電漿
  • 尿
  • 其他樣本類型

第10章 市場估價與預測：依最終用途分類，2022-2035年

  • 居家照護環境
  • 動物醫院
  • 動物診所
  • 其他最終用戶

第11章 市場估價與預測：按地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第12章：公司簡介

  • Zoetis
  • IDEXX Laboratories
  • Thermo Fisher Scientific
  • Virbac
  • Neogen
  • Heska Corporation（Mars Inc.）
  • BioNote
  • MEGACOR Diagnostik
  • Fassisi
  • Swissavans
  • INDICAL Bioscience
  • VetAll Laboratories
  • BioChek
  • Agrolabo
  • Shenzhen Bioeasy Biotechnology
簡介目錄
Product Code: 3455

The Global Veterinary Rapid Tests Market was valued at USD 953.2 million in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 2.3 billion by 2035.

Veterinary Rapid Tests Market - IMG1

The market growth is driven by the ongoing shift from centralized diagnostic laboratories toward point-of-care testing across veterinary care environments, including companion animal clinics and livestock field operations. Expanding pet ownership, increasing focus on preventive animal healthcare, and rising demand for fast diagnostic outcomes are further strengthening market adoption. The growing influence of One Health initiatives is also supporting integrated disease monitoring across animals and humans, reinforcing the importance of rapid diagnostic tools. Continuous cost reductions in lateral flow assay technologies are improving affordability and accessibility across developing and developed regions. In addition, advancements in multiplex testing and digital connectivity solutions are enhancing diagnostic accuracy and enabling real-time data sharing. Rising awareness among pet owners and livestock producers regarding early disease detection is further accelerating utilization rates, making veterinary rapid diagnostics a consistently expanding segment within the broader animal health industry.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$953.2 Million
Forecast Value$2.3 Billion
CAGR9.1%

The rapid test kits segment held 67.6% share in 2025 and is projected to grow at a CAGR of 9.9% through 2035. The dominance of this segment is supported by its recurring consumable demand model, wide clinical applicability across multiple animal diseases, and continuous innovation by manufacturers targeting both companion and livestock health applications. Their ease of use, quick turnaround time, and suitability for on-site testing further strengthen their adoption across veterinary care systems.

The veterinary clinics segment held 39.7% share in 2025 and is projected to grow at a CAGR of 8.6% through 2035. This segment leads due to the high concentration of veterinary service providers and the strong reliance on in-clinic diagnostic testing for timely decision-making. Clinics remain the primary access point for animal healthcare services, particularly for companion animals, where rapid testing supports immediate treatment planning and disease management. Increasing demand for point-of-care diagnostics continues to reinforce their central role in veterinary healthcare delivery.

North America Veterinary Rapid Tests Market accounted for 40.5% share in 2025 and is expected to grow at a CAGR of 8.3% through 2035, maintaining its dominant global position. The region's leadership is supported by high companion animal ownership rates, advanced veterinary care infrastructure, and strong adoption of diagnostic technologies. The United States remains the primary contributor to regional demand, driven by a large base of veterinary practices and increasing emphasis on preventive animal healthcare and early disease detection.

Key market participants include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, Virbac, Neogen, Heska Corporation (Mars Inc.), BioNote, MEGACOR Diagnostik, Fassisi, Swissavans, INDICAL Bioscience, VetAll Laboratories, BioChek, Agrolabo, and Shenzhen Bioeasy Biotechnology. Companies in the veterinary rapid tests market are strengthening their market position through continuous product innovation focused on improving diagnostic speed, accuracy, and ease of use. Many players are expanding their portfolios with multiplex testing solutions capable of detecting multiple pathogens in a single test. Strategic investments in digital diagnostics and connected platforms are enabling real-time data sharing and enhanced clinical decision-making. Firms are also increasing partnerships with veterinary clinics, laboratories, and distributors to improve market penetration. Expansion into emerging markets with rising pet adoption and livestock populations is another key strategy.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research approach
  • 1.3 Quality commitments
    • 1.3.1 GMI AI policy and data integrity commitment
      • 1.3.1.1 Source consistency protocol
  • 1.4 Research trail and confidence scoring
    • 1.4.1 Research trail components
    • 1.4.2 Scoring components
  • 1.5 Data collection
    • 1.5.1 Partial list of primary sources
  • 1.6 Data mining sources
    • 1.6.1 Paid sources
      • 1.6.1.1 Sources, by region
  • 1.7 Base estimates and calculations
    • 1.7.1 Revenue share analysis
    • 1.7.2 Base year calculation
  • 1.8 Forecast model
  • 1.9 Research transparency addendum
    • 1.9.1 Source attribution framework
    • 1.9.2 Quality assurance metrics
    • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Test type trends
    • 2.2.4 Application trends
    • 2.2.5 Animal type trends
    • 2.2.6 Sample type trends
    • 2.2.7 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing number of companion animal population
      • 3.2.1.2 Increasing prevalence of zoonotic diseases in animals
      • 3.2.1.3 Rising demand for rapid test diagnosis over other tests
      • 3.2.1.4 Increasing pet ownership
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited number of infrastructures for veterinary diagnosis
      • 3.2.2.2 Lack of awareness for veterinary health in underdeveloped countries
      • 3.2.2.3 Increasing cost of animal healthcare
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of multiplex and portable rapid testing solutions
      • 3.2.3.2 Expansion of veterinary diagnostics in emerging and rural markets
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
    • 3.4.1 Current technology
    • 3.4.2 Emerging technologies
  • 3.5 Pricing analysis (Driven by Primary Research)
  • 3.6 Regulatory landscape (Driven by primary research)
    • 3.6.1 North America
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 Latin America
    • 3.6.5 Middle East and Africa
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Impact of AI and generative AI on the market
  • 3.10 Future market trends (Driven by primary research)
  • 3.11 Pet population statistics

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Merger and acquisition
    • 4.6.2 Partnership and collaboration
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Rapid test kits
  • 5.3 Rapid test readers

Chapter 6 Market Estimates and Forecast, By Test Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Antigen based rapid test
  • 6.3 Antibody-based rapid test
  • 6.4 Mixed tests

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Viral
  • 7.3 Parasitic
  • 7.4 Bacterial
  • 7.5 Allergies
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Animal Type, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Companion animals
    • 8.2.1 Dogs
    • 8.2.2 Cats
    • 8.2.3 Horses
    • 8.2.4 Other companion animals
  • 8.3 Livestock animals
    • 8.3.1 Cattle
    • 8.3.2 Swine
    • 8.3.3 Poultry
    • 8.3.4 Other livestock animals

Chapter 9 Market Estimates and Forecast, By Sample Type, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 Blood
  • 9.3 Feces
  • 9.4 Serum
  • 9.5 Plasma
  • 9.6 Urine
  • 9.7 Other sample types

Chapter 10 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 10.1 Key trends
  • 10.2 Homecare settings
  • 10.3 Veterinary hospitals
  • 10.4 Veterinary clinics
  • 10.5 Other end users

Chapter 11 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Netherlands
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 UAE

Chapter 12 Company Profiles

  • 12.1 Zoetis
  • 12.2 IDEXX Laboratories
  • 12.3 Thermo Fisher Scientific
  • 12.4 Virbac
  • 12.5 Neogen
  • 12.6 Heska Corporation (Mars Inc.)
  • 12.7 BioNote
  • 12.8 MEGACOR Diagnostik
  • 12.9 Fassisi
  • 12.10 Swissavans
  • 12.11 INDICAL Bioscience
  • 12.12 VetAll Laboratories
  • 12.13 BioChek
  • 12.14 Agrolabo
  • 12.15 Shenzhen Bioeasy Biotechnology